Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03520959
Title Synovate Study for Synovial Sarcoma, Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Immune Design

synovial sarcoma



Age Groups: child | senior | adult
Covered Countries USA | CAN

No variant requirements are available.